为评价广谱抗寄生虫感染药物硝唑尼特(nita zoxanide)单剂量治疗混合感染肠道寄生虫(肠道原虫和蠕虫)儿童的疗效和耐受性,墨西哥Diaz等对墨西哥北部85个家庭的2 72名2～1 4岁儿童做了寄生虫感染的调查,其中6～1 2岁1 84名(6 8% ) ,男性占5 4%。粪便样本采集时间为1 997年3月至1 To evaluate the efficacy and tolerability of a single dose of nita zoxanide, a broad-spectrum antiparasitic drug, in the treatment of children infected with enteric parasites (enteropara and worms), Mexico Diaz et al. Evaluated 85 families in northern Mexico 2 72 children aged 2-14 years were surveyed for parasitic infection, of whom 844 (68%) were 6 to 12 years old and 54% of men. Stool samples were collected from March 1997 to January 1